glp-1 coverage news Paving the way for expanded | Insights & Events Weight-loss, diabetes drugs linked to

Diabetesmellitus (DM) is a group of metabolic diseases classified by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both

Learn the most common and serious GLP-1 side effects, including nausea, constipation, pancreatitis risk, and when to seek medical attention.

Please confirm your status as a healthcare professional to access the content.

Safe & sustainable weight loss based on science

Clinical uses Type 2 Diabetes Mellitus (T2DM): Effective in lowering blood glucose without a significant risk of hypoglycemia

Conclusion: This review synthesizes current evidence on the safety and effectiveness of GLP-1RAs in weight management and potential cardiovascular protection